C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:C. R. Bard Inc (BCR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011718
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral vascular (PVD) and end-stage renal (ESRD) diseases; urology drainage products, fecal and urinary continence products and urological specialty products; specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters and enteral feeding devices; implanted grafts and fixation devices for hernia and soft tissue repairs and hemostats and surgical sealants. Bard offers its products to hospitals, individual health care professionals, extended care facilities and alternate site facilities. The company conducts its operations in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Bard is headquartered in Murray Hill, New Jersey, the US.

C. R. Bard Inc (BCR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
C. R. Bard Acquires Technology from 3DT Holdings 12
Venture Financing 13
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Partnerships 17
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
Equity Offering 18
ClearStream Technologies Completes Private Placement For US$2 Million 18
Debt Offering 19
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Acquisition 21
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc – Key Competitors 43
C. R. Bard Inc – Key Employees 44
C. R. Bard Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 51
Financial Announcements 51
Oct 25, 2017: Bard Announces Third Quarter Results 51
Apr 23, 2017: Bard Announces First Quarter Results 53
Jan 26, 2017: Bard Announces Fourth Quarter Results 54
Oct 25, 2016: Bard Announces Third Quarter Results 55
Jul 26, 2016: Bard Announces Second Quarter Results 56
Apr 27, 2016: Bard Announces First Quarter Results 57
Jan 29, 2016: Bard Announces Fourth Quarter Results 58
Legal and Regulatory 59
May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 59
Jan 08, 2016: Seeger Weiss LLP Reports That IVC Filter Lawsuits Against C.R. Bard Have Been Consolidated In A Multidistrict Litigation 60
Product News 61
02/09/2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 61
Other Significant Developments 62
Apr 06, 2016: SharedClarity Awards Surgical Mesh Contracts for Breast Reconstructive and Hernia Repair Surgeries 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
C. R. Bard Inc, Medical Equipment, Key Facts, 2016 2
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Acquires Technology from 3DT Holdings 12
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
ClearStream Technologies Completes Private Placement For US$2 Million 18
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc, Key Competitors 43
C. R. Bard Inc, Key Employees 44
C. R. Bard Inc, Other Locations 46
C. R. Bard Inc, Subsidiaries 47

★海外企業調査レポート[C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SIL Investments Limited (SILINV):企業の財務及び戦略的SWOT分析
    Summary SIL Investments Limited (SIL), formerly Sutlej Industries Limited is an investment company that provides financial services. The company invests in shares, securities and real estate sectors. It depends on financial and capital markets to serve its customers. SIL also invests from rent, divi …
  • NXP Semiconductors N.V. (NXPI):企業のM&A・提携動向(エネルギー分野)
    Summary NXP Semiconductors N.V. (NXP) is a semiconductor company that provides mixed signal and standard product solutions. It offers radio frequency (RF), analog, interface, power management, security and digital processing products. NXP’s standard products business offers various standard semicond …
  • China National Chemical Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary China National Chemical Corporation (ChemChina) is a state-owned enterprise, which carries out the development and production of chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, basic chemicals, rubber products, oil processing and refining products, an …
  • MTS Systems Corporation (MTSC):企業概要、財務及び戦略的SWOT分析
    Summary MTS Systems Corporation (MTS) is a supplier of high-performance test systems and position sensors. The company’s product portfolio includes test components such as controllers, environmental simulation, grips, fixtures and accessories, software, hydraulic power and distribution and others; a …
  • Credicorp Ltd.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Credicorp Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a …
  • Isramco, Inc. (ISRL):企業財務及び戦略的SWOT分析
    Summary Isramco, Inc. (Isramco) is a mineral exploration company that provides exploration, development and production of oil and natural gas properties. The company acquires, explores, develops and produces oil and natural gas properties in the US and Israel. It offers services such as maintenance, …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Havells India, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Havells India, Ltd. Mergers and …
  • Petro River Oil Corp. (PTRC):企業概要、財務及び戦略的SWOT分析
    Summary Petro River Oil Corp. (Petro River) is an oil and gas company. The company operates in the acquisition, exploration, and development of non-conventional oil and gas properties primarily in North America. It also owns the right to earn interests in approximately 146,000 acres of prospective o …
  • Asahi Kasei Corp (3407)-エネルギー分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • The Ming An (Holdings) Company Limited:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Ming An (Holdings) Company Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Time …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Biomm S.A. (BIOM3)(製薬・医療分野):企業M&A動向
    Summary Biomm S.A. (Biomm) is a biotechnology company. The company develops technology for the production of human insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins, such as calcitonin, interferons and growth hormones. The company offers process …
  • PolyTherics Limited(製薬・医療分野):企業M&A動向
    Summary PolyTherics Limited (PolyTherics) is a biopharmaceutical company. The company offers biopharmaceutical technologies to develop the biopharmaceuticals. It provides various technology for optimising pharmacokinetics and pharmacodynamics to a variety of novel and established therapeutic protein …
  • KCA Deutag Alpha Limited:企業のM&A・提携動向(石油・ガス分野)
    Summary KCA Deutag Alpha Limited (KCA Deutag) is an oil and gas drilling contractor that provides drilling and engineering services for both onshore and offshore oil and gas industry. The company’s major services includes jack-up drilling rigs, self-erect tenders, offshore platform rig management, o …
  • Acteon Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Acteon Group Ltd (Acteon) is an oil and gas company that offers subsea services. The company’s services include survey and monitoring data, risers and moorings, seabed foundation technologies and project support services. Its survey and monitoring data services comprise chain monitoring and …
  • CNO Financial Group, Inc.:企業の戦略・SWOT・財務分析
    SummaryCNO Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報
    Summary PCI Pharma Services (PCI) is a pharmaceutical service provider that offers clinical, manufacturing and packaging solutions. The company offers clinical services such as clinical supplies management, clinical planning and support, project management, IVRS-IWRS, support services and data acces …
  • Blue Nile, Inc.:企業の戦略・SWOT・財務情報
    Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report Summary Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆